Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:IVC

Invacare (IVC) Stock Price, News & Analysis

Invacare logo

About Invacare Stock (NYSE:IVC)

Key Stats

Today's Range
N/A
50-Day Range
$0.35
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IVC Stock News Headlines

Buckeye Trail volleyball stays perfect with key IVC victory
U.S. Government Sparking Crypto Rally
Altcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactly how to find altcoins to buy at low prices right now, when to buy them, and how to position for maximum gains when the approvals hit.tc pixel
Buckeye Trail coasts past Newcomerstown for key IVC win
IL&FS Investment Managers Limited (IVC.NS)
See More Headlines

IVC Stock Analysis - Frequently Asked Questions

Invacare Co. (NYSE:IVC) issued its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to analyst estimates of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 37.76% and a negative net margin of 9.99%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invacare investors own include Pfizer (PFE), Intel (INTC), Exxon Mobil (XOM), Micron Technology (MU), Occidental Petroleum (OXY), Devon Energy (DVN) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
10/27/2021
Today
10/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:IVC
CIK
742112
Employees
3,000
Year Founded
1885

Profitability

EPS (Trailing Twelve Months)
($2.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.56 million
Net Margins
-9.99%
Pretax Margin
-9.38%
Return on Equity
-37.76%
Return on Assets
-7.18%

Debt

Debt-to-Equity Ratio
4.82
Current Ratio
1.32
Quick Ratio
0.78

Sales & Book Value

Annual Sales
$872.46 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.77
Book Value
$5.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
37,760,000
Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:IVC) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners